# The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®

> **NCT05373303** · NA · COMPLETED · sponsor: **PT. Daewoong Infion** · enrollment: 82 (actual)

## Conditions studied

- Chronic Kidney Disease (CKD)

## Interventions

- **BIOLOGICAL:** Recombinant Human Erythropoietin Alpha
- **BIOLOGICAL:** Recombinant Human Erythropoietin Alpha

## Key facts

- **NCT ID:** NCT05373303
- **Lead sponsor:** PT. Daewoong Infion
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-07
- **Primary completion:** 2021-05-15
- **Final completion:** 2022-01-28
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2022-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05373303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05373303, "The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05373303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*